Hand foot skin reaction in cancer patients treated with the multikinase inhibitors sorafenib and sunitinib von Lacouture, M.E., Reilly, L.M., Gerami, P., Guitart, J.

Volltext

Immune‐related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors von Zarbo, A., Belum, V.R., Sibaud, V., Oudard, S., Postow, M.A., Hsieh, J.J., Motzer, R.J., Busam, K.J., Lacouture, M.E.

Volltext

Validation and responsiveness of the English version of the Chemotherapy-Induced Alopecia Distress Scale (CADS) in breast cancer patients von Kraehenbuehl, L., Kang, D., Bang, A. S., Ketosugbo, K. F., Hay, J., Patil, Sujata, Goldfarb, S., Cho, J., Lacouture, M. E.

Volltext

Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies von Naidoo, J., Page, D.B., Li, B.T., Connell, L.C., Schindler, K., Lacouture, M.E., Postow, M.A., Wolchok, J.D.

Volltext

A Dosing/Cross‐Development Study of the Multikinase Inhibitor Sorafenib in Patients With Pulmonary Arterial Hypertension von Gomberg‐Maitland, M, Maitland, M L, Barst, R J, Sugeng, L, Coslet, S, Perrino, T J, Bond, L, LaCouture, M E, Archer, S L, Ratain, M J

Volltext

Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor von Belum, V.R, Benhuri, B, Postow, M.A, Hellmann, M.D, Lesokhin, A.M, Segal, N.H, Motzer, R.J, Wu, S, Busam, K.J, Wolchok, J.D, Lacouture, M.E

Volltext

Development and validation of a prediction index for hand-foot skin reaction in cancer patients receiving sorafenib von Dranitsaris, G., Vincent, M.D., Yu, J., Huang, L., Fang, F., Lacouture, M.E.

Volltext

The risk of nail changes with taxane chemotherapy: a systematic review of the literature and meta-analysis von Capriotti, K., Capriotti, J.A., Lessin, S., Wu, S., Goldfarb, S., Belum, V.R., Lacouture, M.E.

Volltext

The effect of cytotoxic chemotherapy on the risk of high-grade acneiform rash to cetuximab in cancer patients: a meta-analysis von Balagula, Y., Wu, S., Su, X., Lacouture, M.E.

Volltext

The PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibitors) syndrome von Lacouture, M.E., Lai, S.E.

Volltext

Olmutinib‐induced palmoplantar keratoderma von Chen, K.L., Cho, Y.T., Yang, C.W., Sheen, Y.S., Liang, C.W., Lacouture, M.E., Chu, C.Y.

Volltext

Regorafenib-associated hand–foot skin reaction: practical advice on diagnosis, prevention, and management von McLellan, B., Ciardiello, F., Lacouture, M.E., Segaert, S., Van Cutsem, E.

Volltext

Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines von Lacouture, M.E., Sibaud, V., Gerber, P.A., van den Hurk, C., Fernández-Peñas, P., Santini, D., Jahn, F., Jordan, K.

Volltext

Taking it in the chin: vitamin K1 for the prevention of acneiform rash von Lacouture, M.E.

Volltext

Analysis of dermatologic events in patients with cancer treated with lapatinib von Lacouture, M. E, Laabs, S. M, Koehler, M, Sweetman, R. W, Preston, A. J, Di Leo, A, Gomez, H. L, Salazar, V. M, Byrne, J. A, Koch, K. M, Blackwell, K. L

Volltext

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group von Puzanov, I, Diab, A, Abdallah, K, Bingham, 3rd, C O, Brogdon, C, Dadu, R, Hamad, L, Kim, S, Lacouture, M E, LeBoeuf, N R, Lenihan, D, Onofrei, C, Shannon, V, Sharma, R, Silk, A W, Skondra, D, Suarez-Almazor, M E, Wang, Y, Wiley, K, Kaufman, H L, Ernstoff, M S

Volltext

Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies von Naidoo, J, Page, D B, Li, B T, Connell, L C, Schindler, K, Lacouture, M E, Postow, M A, Wolchok, J D

Volltext

A phase II study (ARCHER 1042) to evaluate prophylactic treatment of dacomitinib-induced dermatologic and gastrointestinal adverse events in advanced non-small-cell lung cancer von Lacouture, M.E., Keefe, D.M., Sonis, S., Jatoi, A., Gernhardt, D., Wang, T., Doherty, J.P., Giri, N., Nadanaciva, S., O'Connell, J., Sbar, E., Piperdi, B., Garon, E.B.

Volltext

reply to the letter to the editor ‘Possible determinants of VSL#3 probiotic failure in preventing gastrointestinal adverse events associated with dacomitinib in patients with advan... von Lacouture, M.E.

Volltext

IgE blockade with omalizumab reduces pruritus related to immune checkpoint inhibitors and anti-HER2 therapies von Barrios, D.M., Phillips, G.S., Geisler, A.N., Trelles, S.R., Markova, A., Noor, S.J., Quigley, E.A., Haliasos, H.C., Moy, A.P., Schram, A.M., Bromberg, J., Funt, S.A., Voss, M.H., Drilon, A., Hellmann, M.D., Comen, E.A., Narala, S., Patel, A.B., Wetzel, M., Jung, J.Y., Leung, D.Y.M., Lacouture, M.E.

Volltext